Showing all results Page 2 of 17

The future of bioprocessing across Asia Pacific

May 14th, 2024

The APAC bioprocessing market was one of the best performing sectors between 2022-2023—growing at about 18% annually—driven by pandemic spending. However, with post-pandemic normalisation and increased cost of financing, this has dropped to a flatline between 2022-2023.

  • Campaign
  • Life sciences
  • Asia

Orthopaedics robotics in Asia Pacific

May 8th, 2024

Joint robotics sees the highest penetration in knee while hip is an emerging segment
Knee and hip procedures are growing across APAC
Robotic installations are increasing year-on-year

  • Clearstate Insights
  • Orthopaedic & Spine Surgery
  • Robotic surgery
  • Surgical device
  • Asia
  • Global
  • Surgical Gateway

Disease trends in Vietnam

March 21st, 2024

Vietnam’s population will continue to grow during 2018-2027. We project an annual average increase of 0.6% in 2023-27, to more than 100m by the end of the forecast period.

  • Clearstate Insights
  • Disease Trends
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Global
  • Vietnam
  • IVD Gateway

外科手術のDX推進を後押しする6つの要因

March 14th, 2024

デジタルヘルステクノロジーは、世界中の外科手術を変革しています。手術ロボット、人工知能(AI)、5Gを活用し遠隔手術のようなテクノロジーは、外科治療の提供における課題を解決し、より精密で先進的な治療法に対する患者の要求に応えていきます。

  • Campaign
  • General surgery
  • Surgical device
  • Asia

政府の施策が中国の手術ロボット市場に及ぼす影響

March 13th, 2024

政府によるデジタル医療推進の流れを受け、中国における手術ロボットの導入は今後加速する可能性が高い。“次世代AI産業”の推進を謳い2018年に開始された『3カ年行動計画』は、手術ロボットのニーズ拡大を受けたものだ。

  • Clearstate Insights
  • China Segmentation Surgical Devices Tracker
  • General surgery
  • Robotic surgery
  • Surgical device
  • Asia
  • China Segmentation Surgical Devices Tracker
  • General Surgery
  • Robotic surgery
  • Surgical Gateway

政府の施策が韓国の手術ロボット市場に及ぼす影響

March 13th, 2024

韓国では、医療産業における長期的成長の牽引役として、デジタル技術の重要性が高まっている。パンデミック後に発表された韓国版『ニューディール』構想では、2025年までの経済開発関連費として1300億ドルを超える予算が盛り込まれた。重点医療分野でのロボティクス活用といったデジタル医療の推進策を含む『デジタル・ニューディール』も、その一環として重視されている。

  • Clearstate Insights
  • General surgery
  • Robotic surgery
  • Surgical device
  • Asia
  • General Surgery
  • Robotic surgery
  • Surgical Gateway

Disease trends in China

February 14th, 2024

China’s population has reached its peak and is projected to remain above 1.39bn until 2035. After a brief rebound, the number of newborns is expected to return to its previous downward trend owing to a combination of fewer women of reproductive age and declining fertility rates.

  • Clearstate Insights
  • Disease Trends
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Asia
  • Infectious Diseases Testing Monitor
  • IVD Gateway

China’s IVD market – sample report

February 7th, 2024

China has been aggressively implementing various policies to control healthcare costs. In recent years, volume-based procurement (VBP) has been one of the most impactful policies, significantly reshaping China’s IVD market landscape.

  • Campaign
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Segment Trend Report samples
  • Asia

Thailand’s IVD market – sample report

February 7th, 2024

The Centralised Diagnostics (CDx) market in Thailand experienced an overall growth of 10.7% from 2021 to 2022, as the market began its recovery from the COVID-19 pandemic,
emerging as the leading contributor to the overall IVD market at the end of this period.

  • Campaign
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Segment Trend Report samples
  • Asia